Alembic Pharmaceuticals informs about disclosure

17 Jun 2024 Evaluate
Alembic Pharmaceuticals has informed that the company has received the USFDA Final approval for Icatibant Injection 30 mg/3mL (10 mg/mL) Single dose prefilled syringe. This is the first peptide product approval from the USFDA received by the Company.

The above information is a part of company’s filings submitted to BSE.

Alembic Pharma Share Price

1041.80 3.60 (0.35%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.